FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available.

FDA Alerts Public to Possible Health Risk Associated with Certain Tamarind Candy Lollipops from Mexico

Spanish version

FDA is warning consumers to avoid purchasing or consuming tamarind candy lollipops labeled Dulmex brand *Bolirindo* because of high levels of lead that may be associated with the product - especially its wrapper. People, especially children, who consume high levels of lead can suffer serious damage to their central nervous systems - sometimes leading to permanent neurological damage.

Routine lead level testing of children conducted by the California Department of Health Services revealed at least three cases where 2 year old children may have suffered elevated lead levels as a result of contact with this candy. These findings lead the California Department of Health Services and FDA to analyze this product for lead contamination. Although sampling and analyses of this product continues, preliminary findings indicate that at least the lollipop wrapper*s exterior may have exceedingly high concentrations of lead (21,000 parts per million).

In light of these preliminary findings and reported injuries FDA is urging consumers not to consume these lollipops and to keep them out of childrens* hands. Eating the lollipops may expose them to dangerously high levels of lead, especially if the candy becomes damp or if the wrapper is chewed or eaten. Anyone who suspects they or their child may have consumed these lollipops may want to consult their doctor about having their lead level checked.

The product is a soft, dark brown, tamarind fruit candy lollipop on a white or orange stick. It is wrapped in an orange-red wrapper with *BOLIRINDO* in white lettering and picture of a brown tamarind fruit. The product is known to be distributed in California, but may also be present in other parts of the country, particularly in Southwestern states.

This is a mirror of the page at HTTP://www.fda.gov/bbs/topics/ANSWERS/2001/ANS01079.html